Attys Denied Fee Set-Aside In Generics Antitrust Case

By Christopher Cole · October 8, 2019, 5:03 PM EDT

Lawyers for two sets of litigants suing generic-drug makers in a price-fixing class action can't get a 10% set-aside from any future damages that parties taking their own direct actions ultimately...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order on Motion for Miscellaneous Relief

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Recent Articles By Christopher

November 28, 2023
FCC To Ease Signing-Up For Rural Health Funding Projects
November 28, 2023
Advocates Worry 988 Hotline Georouting Will Get Delayed
September 12, 2023
Lead-Covered Verizon Cables Put Workers At Risk, Suit Says
July 20, 2023
FCC Requires Providers To Report 988 Crisis Line Outages
April 24, 2023
Shentel Fined $227K For 911 Audio Outages
January 26, 2023
FCC Aims To Improve Outage Reporting For 988 Hotline
January 26, 2023
FCC Reworks Payment Model For Rural Health Connectivity
January 20, 2023
FCC Urged To Keep Telehealth Rates' Status Quo For Now
July 27, 2022
House Votes To Extend FCC's Spectrum Auction Powers
April 05, 2022
Windstream To Pay $1.2M In FCC Settlement Over Rural Rates